| Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe M Souli, I Galani, H Giamarellou Eurosurveillance 13 (47), 2008 | 757 | 2008 |
| Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues V Miriagou, G Cornaglia, M Edelstein, I Galani, CG Giske, M Gniadkowski, ... Clinical microbiology and infection 16 (2), 112-122, 2010 | 572 | 2010 |
| An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular … M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ... Clinical infectious diseases 50 (3), 364-373, 2010 | 471 | 2010 |
| Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster A Antoniadou, F Kontopidou, G Poulakou, E Koratzanis, I Galani, ... Journal of Antimicrobial Chemotherapy 59 (4), 786-790, 2007 | 344 | 2007 |
| Colistin susceptibility testing by Etest and disk diffusion methods I Galani, F Kontopidou, M Souli, PD Rekatsina, E Koratzanis, J Deliolanis, ... International journal of antimicrobial agents 31 (5), 434-439, 2008 | 214 | 2008 |
| Evaluation of different laboratory tests for the detection of metallo-β-lactamase production in Enterobacteriaceae I Galani, PD Rekatsina, D Hatzaki, D Plachouras, M Souli, H Giamarellou Journal of antimicrobial chemotherapy 61 (3), 548-553, 2008 | 203 | 2008 |
| In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development M Souli, I Galani, S Boukovalas, MG Gourgoulis, Z Chryssouli, ... Antimicrobial agents and chemotherapy 55 (5), 2395-2397, 2011 | 150 | 2011 |
| Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital M Souli, FV Kontopidou, E Papadomichelakis, I Galani, A Armaganidis, ... Clinical infectious diseases 46 (6), 847-854, 2008 | 150 | 2008 |
| Colistin: still a lifesaver for the 21st century? I Karaiskos, M Souli, I Galani, H Giamarellou Expert opinion on drug metabolism & toxicology 13 (1), 59-71, 2017 | 136 | 2017 |
| Colonization and infection by colistin‐resistant Gram‐negative bacteria in a cohort of critically ill patients F Kontopidou, D Plachouras, E Papadomichelakis, G Koukos, I Galani, ... Clinical Microbiology and Infection 17 (11), E9-E11, 2011 | 135 | 2011 |
| Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece I Galani, M Souli, GL Daikos, Z Chrysouli, G Poulakou, M Psichogiou, ... Journal of Chemotherapy 24 (4), 191-194, 2012 | 128 | 2012 |
| Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci V Sakka, S Tsiodras, L Galani, A Antoniadou, M Souli, I Galani, ... Clinical Microbiology and Infection 14 (1), 14-21, 2008 | 123 | 2008 |
| Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens I Karaiskos, I Galani, M Souli, H Giamarellou Expert opinion on drug metabolism & toxicology 15 (2), 133-149, 2019 | 101 | 2019 |
| Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016 I Galani, I Karaiskos, I Karantani, V Papoutsaki, S Maraki, V Papaioannou, ... Eurosurveillance 23 (31), 1700775, 2018 | 97 | 2018 |
| In Vitro Interaction of Colistin and Rifampin on Multidrug-Resistant Pseudomonas aeruginosa EJ Giamarellos-Bourboulis, H Sambatakou, I Galani, H Giamarellou Journal of chemotherapy 15 (3), 235-238, 2003 | 95 | 2003 |
| Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures T Panagea, I Galani, M Souli, P Adamou, A Antoniadou, H Giamarellou International journal of antimicrobial agents 37 (2), 124-128, 2011 | 93 | 2011 |
| Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-β-lactamase-producing Klebsiella pneumoniae isolates? M Souli, PD Rekatsina, Z Chryssouli, I Galani, H Giamarellou, ... Antimicrobial agents and chemotherapy 53 (5), 2133-2135, 2009 | 93 | 2009 |
| Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance I Galani, K Nafplioti, P Adamou, I Karaiskos, H Giamarellou, M Souli BMC infectious diseases 19, 1-12, 2019 | 92 | 2019 |
| Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study I Karaiskos, GL Daikos, A Gkoufa, G Adamis, A Stefos, S Symbardi, ... Journal of Antimicrobial Chemotherapy 76 (3), 775-783, 2021 | 87 | 2021 |
| Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates M Souli, I Galani, D Plachouras, T Panagea, A Armaganidis, G Petrikkos, ... Journal of Antimicrobial Chemotherapy 68 (4), 852-857, 2013 | 82 | 2013 |
